Neudle.com: "sinemet"

Differential
(Click to cross reference)

abdominal protrusion

acetylcholine

acromegaly

advances in neurology

adverse drug reaction

affective disorders

akathisia

akinesia of eyelid function

alcohol, neurologic complications with

alcoholism

algorithm

alien hand syndrome

alpha methyldopa hydrazine

amphetamines, dyskinesia associated with

amygdala

anasarca

anemia, iron deficiency

ankle edema

anticholinergic drugs

anticholinergic drugs, side effects of

apraxia of eyelid opening

apraxia, constructional

aprazolam

aqueduct of Sylvius, stenosis

arm swing, reduced

arrhythmia, cardiac

artane

arterial dissection, aorta, cerebral symptoms with

aspartate aminotransferase

aspiration

asterixis

ataxia

attention deficit disorder with hyperactivity

atypical

audiogram

auditory and vestibular pathways

autonomic cardiovascular reflexes

autonomic dysfunction

autonomic dysfunction, evaluation of

autonomic nervous system

axillary nerve

Babinski sign

ballismus, bilateral

basal ganglia, lesion, bilateral

brain transplantation

burst suppression pattern, electroencephalogram

CAT scan, emission, abnormal

catecholamine

catechol-o-methyltransferase inhibitor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction, subcortical

cerebral ischemia

cerebral palsy

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

Charcot's sign

children

chorea

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

controversies in neurology

Coombs test, positive

cortical-basal ganglionic degeneration

cyst, arachnoid, infant

dantrolene sodium

degenerative diseases of CNS

dementia, subcortical

dementia, treatment of

deprenyl

depression

desipramine

developmental milestones, loss of

differential diagnosis

dilantin

diplopia

disability rating scale, neurological

disability, neurological

diurnal variation

dopa responsive dystonia

dopamine

dopamine agonist

dopamine receptor

dopamine receptor, D2

drug induced neurologic disorders

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dysphagia

dyspnea

dystonia

dystonia musculorum deformens

dystonia, children

dystonia, etiology of

dystonia, evaluation of

dystonia, focal

dystonia, painful

dystonia, prevalence of

dystonia, symptomatic

dystonia, treatment of

efficacy

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electroencephalogram, triphasic delta waves

encephalopathy, progressive

epidemiology of neurology

extrapyramidal movement disorder, progressive

eye movement, disorders of

fine motor function, impaired

gamma amino butyric acid

gastrointestinal bleeding

gastrostomy

gaze palsy

gaze palsy, supranuclear

genetic neurologic disorders

genetic screening

genetic testing

Gilles de la Tourette syndrome

hallucination, visual

haloperidol

handwriting

head injury

head injury, brain stem lesion after

head injury, prognosis in

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

Huntington's chorea, presymptomatic detection of

hydrocephalus

hydroxyindole acetic acid 5(5HIAA)

iatrogenic neurologic disorders

intranasal medication

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, intravenous

L-dopa, liquid

L-dopa, plasma concentration

L-dopa, potentiators of

Lewy body disease, diffuse

limbic system

lisuride

livedo reticularis

liver function enzymes

lobar atrophy

locus ceruleus, lesion of

lorazepam

madopar

manganese intoxication

memory, defect of recent

memory, impairment of

mental status, abnormal

methysergide

metoclopramide

microangiopathy, brain

migraine, treatment of

misdiagnosis

mitochondrial disease

molecular genetics

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

multiple sclerosis, diet in

multiple sclerosis, treatment of

multiple system atrophy

muscle atrophy, static

myasthenic syndrome, treatment of

neuroleptic malignant syndrome

neuroleptic sensitivity

neuroleptic, atypical

neurologic disease, diagnoses of

neurologic signs

neurologist

neuromyotonia

neuronal degeneration

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, peripheral

neuroprotective agents

nigrostriatal pathway

norepinephrine

nortriptyline

obsessive-compulsive disorder

occupational neurologic disorders

ocular myopathy

ocular myopathy, differential diagnosis

olanzapine

old age, neurology of

ondansetron

ophthalmoplegia

oral contraceptives

oral contraceptives, choreiform movements with

orthostatic hypotension

orthostatic hypotension, idiopathic

orthostatic hypotension, treatment of

parasympathetic nervous system

paresthesias

parkin gene

Parkinson disease

Parkinson disease, akinetic form

Parkinson disease, arteriosclerotic

Parkinson disease, axial symptoms

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, diet restricted in protein

Parkinson disease, differential diagnosis of

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, heterogeneity of

Parkinson disease, juvenile

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, rapid progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, wearing off

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

parsidol

pathologic gambling

patient information and support

penguin silhouette sign

pergolide

periodic limb movements

periodic movements during sleep

persistent vegetative state

personality change

phenothiazine

phenothiazine, dyskinesia associated with

pregnancy, neurologic complications in

pretectal syndrome

prevention of neurologic disorders

procyclidine

prognosis

progressive neurologic disorder

progressive supranuclear palsy

psychiatric problems in neurologic disorders

psychological testing, neurologic problems

psychomotor retardation

pure autonomic failure

pyridoxine

pyridoxine deficiency

pyruvate-kinase deficiency anemia

reserpine and reserpine like drugs

respiratory dyskinesias

restless leg syndrome

retrocollis

retropulsion

reversible neurologic disorder

ropinirole, prolonged release

saccadic eye movements, abnormal

scoliosis

seizure

seizure, pyridoxine dependent

selective serotonin reuptake inhibitors

sequencing difficulty

serotonin

serum alanine aminotransferase

short stature

shunt procedure, ventricular-complications of

Shy-Drager syndrome

sinemet

single photon emission computed tomography

skin, biopsy

sleep

sleep pathology and physiology

small vessel disease

solvent

speech disorder

speech disorder, childhood

speech, soft

spinocerebellar ataxia

spinocerebellar ataxia type 1

spinocerebellar ataxia type 2

spinocerebellar ataxia type 3/Machado Joseph disease

Stalevo

stare

status epilepticus

stem cell transplantation

stereotyped behavior

stereotyped behavior, drug induced

stereotypy

steroid therapy, CNS treatment and complications with

stimulation, deep brain

subcortical U fibers

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

sweating

sweating, abnormality of

sympathetic nervous system

sympathomimetic drugs

syncope

syphilis, neurologic complications with

toxins, nervous system

trauma

trazodone

treatment of neurologic disorder

tremor, thalamic stimulation for suppression of

tremor, treatment of

tricyclic antidepressant

trigeminal neuralgia

trinucleotide repeats

tripping

twins

tyrosine hydroxylase deficiency

upgaze, paralysis of

urinary incontinence

valium

varicella zoster virus

varicella zoster virus, encephalitis

vertigo, treatment of

vision, blurred

visual impairment

visual symptoms

visuospatial disturbance

walking, difficulty with

white matter disease, subcortical

Showing articles 0 to 50 of 231 Next >>

A Young Woman With Hypertonia, Severe Scoliosis, and Encephalopathy
JAMA Neurol 81:83-84, Hua,L.,et al, 2024

A 6-Year-Old Girl with Progressive Toe Walking
Neurol 98:e769-e773, Libdeh, A.A. & Ibrahim, A., 2022

Diagnosis and Treatment of Parkinson Disease
JAMA 323:548-560, Armstrong, M.J. & Okun, M.S., 2020

Vitamin B6 Deficiency Presenting with New-Onset Epilepsy and Status Epilepticus in a Patient with Parkinson Disease
Neurol 94:e2605-e2607, Modica, J.S.,et al, 2020

Involuntary Groaning Induced by Levodopa Therapy in a Patient With Progressive Supranuclear Palsy
JAMA Neurol 77:1569, Park, J.E., 2020

When to Start Levodopa Therapy for Parkinsons Disease
NEJM 380:389-390, Bressman, S. & Saunders-Pullman, R., 2019

A 56-year-old Man with Cognitive Impairment and Difficulty Tying his Necktie
Neurol 85:e116-e122, Baker, J.M.,et al, 2015

Disturbances of Cerebrospinal Fluid, Including Hydrocephalus, Pseudotumor Cerebri, and Low-Pressure Syndromes, Parkinsonism and Midbrain Syndromes with Hydrocephalus and Shunting
Adams & Victors Principles of Neurology, Chp 30, pg 627, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Parkinson Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1082, Ropper, A.H.,et al, 2014

Withdrawing Amantadine in Dyskinetic Patients with Parkinson Disease
Neurol 82:300-307, Ory-Magne, F.,et al, 2014

Long-Term Effectivenss of Dopamine Agonists and Monoamine Oxidase B Inhibitors Compared with Levodopa as Initial Treatment for Parkinsons Disease (PD MED): A Large, Open-Label, Pragmatic Randomised Trial
Lancet 383: Doi: 10.1016/S0140-6736, PD MED Collaborative Group, 2014

Neurostimulation for Parkinsons Disease with Early Motor Complications
NEJM 368:610-622, Rau, W.,et al, 2013

Parkin Disease
JAMA Neurol 70:571-579, Doherty, K.,et al, 2013

Dopa-Responsive Dystonia Revisited
Arch Neurol 69:1558-1562, Tadic, V.,et al, 2012

A Meta-Regression of the Long-Term Effects of Deep Brain Stimulation on Balance and Gait in PD
Neurol 75:1292-1299, St. George,R.J.,et al, 2010

Othello Syndrome in Parkinson Disease Patients Without Dementia
The Neurologist 15:34-36, Cannas,A.,et al, 2009

Long-Term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Arch Neurol 66:563-570, Parkinson Sutdy Group CALM Cohort Investigators, 2009

Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009

Progressive Supranuclear Palsy: A Current Review
The Neurologist 14:79-88, Lubarsky,M. &Juncos,J.L., 2008

Fourteen-Year Final Report of the Randomized PDRG-UK Trial Comparing Three Treatments in PD
Neurol 71:474-480.470, Katzenschlager,R.,et al., 2008

Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
Arch Neurol 65:1604-1611, Cilia,R.,et al, 2008

Levodopa for the Treatment of Parkinsons Disease
NEJM 359:2468-2476, LeWitt,P.A., 2008

Ropinirole 24-Hour Prolonged Release: Randomized, Controlled Study in Advanced Parkinson Disease
Neurol 68:1108-1115, Pahwa,R.,et al, 2007

Treatment Options in the Modern Management of Parkinson Disease
Arch Neurol 64:1083-1088, Schapira,A.H.V., 2007

Dopamine-Responsive Dystonia
eMedicine (Apr), Nikhar,N.K., 2006

Practice Parameter: Neuroprotective Strategies and Alternative Therapies for Parkinson Disease (An Evidence-Based Review)
Neurol 66:976-982, Suchowersky,O.,et al, 2006

Clinicopath Conf, Dopamine-Responsive-Dystonia Caused by a Mutation in the GCH1 Gene
NEJM 355:831-839, Case 26-2006, 2006

Vascular Parkinsonism and Dementia in a CADASIL Case with Intact Nigrostriatal Dopaminergic System
Akt Neurol 33: Suppl, Wegner,F.,et al, 2006

A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations
Arch Neurol 62:241-248, The PRESTO Study, 2005

"Levodopa Phobia": A New Iatrogenic Cause of Disability in Parkinson Disease
Neurol 64:923-924, Kurlan, R., 2005

Rasagiline as an Adjunct to Levodopa in Patients With Parkinsons Disease and Motor Fluctuations (LARGO, Lasting Effect in Adjunct Therapy With Rasagiline Given Once Daily, Study)
Lancet 365:947-954, 914, Rascol,O., et al, 2005

Short-Term Paroxetine Treatment Does Not Alter the Motor Response to Levodopa in PD
Neurol 64:1797-1798, Chung,K.A.,et al, 2005

The Role of Levodopa in the Management of Dementia With Lewy Bodies
JNNP 76:1200-1203, Moloy,S.,et al, 2005

Diagnosis and Initial Management of Parkinsons Disease
NEJM 353:1021-1027, Nutt,J.G.&Wooten,G.F., 2005

Levodopa Addiction in Idiopathic Parkinson Disease
Neurol 65:1508, Borek,L.L &Friedman,J.H., 2005

Diagnosis and Management of Dementia with Lewy Bodies
Neurol 65:1863-1872, McKeith,I.G.,et al, 2005

Effect of Levodopa Treatment for Parkinsonism in Welders
Neurol 62:730-733, Koller,W.C.,et al, 2004

Stalevo for Parkinson's Disease
The Medical Letter 46:39, , 2004

Levodopa and the Progression of Parkinson's Disease
NEJM 351:2498-2508, The Parkinson Study Group, 2004

Restless Legs Syndrome
NEJM 348:2103-2109, Earley,C.J., 2003

Awakenings From Persistent Vegetative State: Report of Three Cases With Parkinsonism and Brain Stem Lesions on MRI
JNNP 74:1571-1573, Matsuda,W.,et al, 2003

Treatments of Parkinson Disease
Arch Neurol 60:1680-1684, Shults,C.W., 2003

Levodopa Addiction in Non-Parkinsonian Patients
Neurol 61:1451, Steiner,I. &Wirguin,I., 2003

Subthalamic DBS Replaces Levodopa in Parkinson's Disease
Neurol 58:396-401, Vingerhoets,F.J.G.,et al, 2002

Practice Parameter: Initiation of Treatment for Parkinson's Disease: An Evidence-based Review
Neurol 58:11-17, Miyasaki,J.M.,et al, 2002

Impact of Sustained Deprenyl (Selegiline) in Levodopa-Treated Parkinson's Disease: A Randomized Placebo-Controlled Extension of the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism Trial
Ann Nuerol 51:604-612, Shoulson,I.,et al, 2002

Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002

Effects of Bilateral Subthalamic Nucleus Stimulation on Parkinsonian Gait
Neurol 57:144-146, Stolze,H.,et al, 2001

Ten-year Follow-up of Three Different Initial Treatments in De-novo PD
Neurol 57:1687-1694, Lees,A.J.,et al, 2001

Showing articles 0 to 50 of 231 Next >>